197 related articles for article (PubMed ID: 22584870)
1. Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies.
Fahim A; Chong MC; Crooks MG; Hart SP
Lung; 2012 Aug; 190(4):451-8. PubMed ID: 22584870
[TBL] [Abstract][Full Text] [Related]
2. Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis.
Taillé C; Grootenboer-Mignot S; Boursier C; Michel L; Debray MP; Fagart J; Barrientos L; Mailleux A; Cigna N; Tubach F; Marchal-Sommé J; Soler P; Chollet-Martin S; Crestani B
Am J Respir Crit Care Med; 2011 Mar; 183(6):759-66. PubMed ID: 20935114
[TBL] [Abstract][Full Text] [Related]
3. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.
Cha SI; Groshong SD; Frankel SK; Edelman BL; Cosgrove GP; Terry-Powers JL; Remigio LK; Curran-Everett D; Brown KK; Cool CD; Riches DW
Am J Respir Cell Mol Biol; 2010 Feb; 42(2):140-8. PubMed ID: 19372246
[TBL] [Abstract][Full Text] [Related]
4. Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF.
Mills R; Mathur A; Nicol LM; Walker JJ; Przybylski AA; Mackinnon AC; Howie SEM; Wallace WAH; Dransfield I; Hirani N
J Immunol Res; 2019; 2019():1845128. PubMed ID: 31098385
[TBL] [Abstract][Full Text] [Related]
5. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
Varma S; Mahavadi P; Sasikumar S; Cushing L; Hyland T; Rosser AE; Riccardi D; Lu J; Kalin TV; Kalinichenko VV; Guenther A; Ramirez MI; Pardo A; Selman M; Warburton D
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L405-19. PubMed ID: 24375798
[TBL] [Abstract][Full Text] [Related]
6. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
[TBL] [Abstract][Full Text] [Related]
7. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
8. Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients.
Beltramo G; Thabut G; Peron N; Nicaise P; Cazes A; Debray MP; Joannes A; Castier Y; Mailleux AA; Frija J; Pradère P; Justet A; Borie R; Dombret MC; Taille C; Aubier M; Crestani B
Respir Med; 2018 Feb; 135():15-21. PubMed ID: 29414448
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
Gan H; McKenzie R; Hao Q; Idell S; Tang H
PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.
Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M
PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812
[TBL] [Abstract][Full Text] [Related]
11. Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis.
Maldonado M; Salgado-Aguayo A; Herrera I; Cabrera S; Ortíz-Quintero B; Staab-Weijnitz CA; Eickelberg O; Ramírez R; Manicone AM; Selman M; Pardo A
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):77-86. PubMed ID: 29373068
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
13. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis.
Borie R; Quesnel C; Phin S; Debray MP; Marchal-Somme J; Tiev K; Bonay M; Fabre A; Soler P; Dehoux M; Crestani B
PLoS One; 2013; 8(1):e53736. PubMed ID: 23341987
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
[TBL] [Abstract][Full Text] [Related]
17. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.
Rindlisbacher B; Schmid C; Geiser T; Bovet C; Funke-Chambour M
Respir Res; 2018 Jan; 19(1):7. PubMed ID: 29321022
[TBL] [Abstract][Full Text] [Related]
19. Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.
Schruf E; Schroeder V; Le HQ; Schönberger T; Raedel D; Stewart EL; Fundel-Clemens K; Bluhmki T; Weigle S; Schuler M; Thomas MJ; Heilker R; Webster MJ; Dass M; Frick M; Stierstorfer B; Quast K; Garnett JP
FASEB J; 2020 Jun; 34(6):7825-7846. PubMed ID: 32297676
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
